CLINICAL_TRIALS
trial_result
· 2015-06-08
Clinical Trial Update: Study to Evaluate the Potential of Air Structuring Protein to Elicit Allergic Reactions in Mold Sensitized People [NA]
Summary
A completed study evaluated whether Air Structuring Protein could elicit allergic reactions in people with mold allergy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Unilever SEAC | Conditions: Allergy to Mold | NA | Status: COMPLETED